Affinivax
Cambridge, US · Founded 2014 · 6 known investors
Find your way into Affinivax
Affinivax was a clinical-stage biopharmaceutical company that developed next-generation pneumococcal vaccines using its proprietary Multiple Antigen Presenting System (MAPS) platform technology. The company has been acquired by GSK.
Founders & leadership
Affinivax was founded in 2014 by Richard Malley.
Board
RM
Robert MoreBoard director
FH
Frances HellerBoard director
GS
George SiberBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$233M disclosed across 2 of 3 rounds · 2017–2021
▶$226MraisedJan 2021 · 27 investors · BiotechnologyRule 506(b)
▶$226MraisedJan 2021 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard MalleyDirector
- Frances HellerDirector
- Steven BruggerExecutive Officer, Director
- Robert MoreDirector
- George SiberDirector
- Steven AltschulerDirector
- Andrew HackDirector
- Offering amount
- $226M
- Amount sold
- $226M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJan 2018 · 5 investors · BiotechnologyRule 506(b)
▶$7MraisedJan 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard MalleyDirector
- Robert MoreDirector
- Frances HellerDirector
- Kamran TavangarExecutive Officer
- George SiberDirector
- Steven BruggerExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
BrainChild Bio raises over $100 million to treat kids’ cancers with CAR-Tscen.acs.org · Sep 2026Frequently asked questions
- What does Affinivax do?
- Affinivax was a clinical-stage biopharmaceutical company that developed next-generation pneumococcal vaccines using its proprietary Multiple Antigen Presenting System (MAPS) platform technology. The company has been acquired by GSK.
- Who founded Affinivax?
- Affinivax was founded by Richard Malley in 2014.
- Who are Affinivax's investors?
- Affinivax's investors include Bain Capital Life Sciences, EcoR1 Capital, Foresite Capital, Bain Capital, Rock Springs Capital, T. Rowe Price.
- How much funding has Affinivax raised?
- Affinivax has disclosed $233M raised across 2 of its 3 known rounds.
- Where is Affinivax headquartered?
- Affinivax is headquartered in Cambridge, US.